Shannon J. Simpson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shannon J. Simpson has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
- Graham L. Hall
Children's Lung Health, Wal‐yan Respiratory Research Centre Telethon Kids Institute Nedlands Western Australia Australia
24 shared publications - Jennifer Jane Pillow
School of Human Sciences, The University of Western Australia, Perth, Western Australia, Australia
7 shared publications - Stephen Michael Stick
Telethon Kids Institute
7 shared publications Andrew C. Wilson
Wal‐Yan Respiratory Research Centre, Telethon Kids Institute Perth Children's Hospital Nedlands Australia
6 shared publications- Denby J. Evans
Curtin University and Telethon Kids Institute, Nedlands, Australia
5 shared publications - Kathryn Angela Ramsey
Division of Paediatric Respiratory Medicine and Allergology, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
5 shared publications
Latest Publications
- Open Access
- 4 February 2025
- Published by BMJ in BMJ Paediatrics Open
- Vol. 9 (1) , e003050
Research priorities for preterm lung health research across the lifespan: a community priority setting partnership
Background: It is essential to embed patient and public perspectives into every stage of the research journey, including setting the future research agenda. The substantial gaps in our understanding of prematurity-associated lung disease presented a timely opportunity to determine the community’s research priorities. Objective: To conduct a priority setting partnership (PSP) to determine the top 10 research priorities for preterm lung health. Design: We undertook a modified James Lind Alliance methodology comprising three main stages: (1) an idea generating survey with open questions to ascertain the community’s most important ideas for future preterm lung health research, (2) prioritisation survey to distill the main themes into a shortlist of 20 and (3) consensus workshop where participants were tasked with ranking their final top 10. This PSP is reflective of the view of preterm-born individuals, parents of preterm children and healthcare professionals in an Australian healthcare setting. Results: We collated 144 submissions from the idea generating survey from which 27 prioritisation themes were developed. From the 150 prioritisation survey responses, the 20 themes receiving the most votes were taken to the consensus workshop . Participants identified the following top 10: (1) lifelong impacts; (2) interventions, treatments or supports; (3) ongoing lung health follow-up; (4) diagnostic tools, resources and education for primary healthcare providers; (5) resources to inform and empower families; (6) relationship to physical health and developmental issues; (7) preventing and/or treating lung infections; (8) additional supports, resources and research for minority groups; (9) impact on mental well-being; and (10) likelihood of asthma diagnosis. Conclusion: Priorities identified through the PSP will be invaluable in informing future research into prematurity-associated lung disease.
- 4 February 2025
- Published by BMJ in BMJ Paediatrics Open
- Vol. 9 (1) , e003050
Open AccessResearch priorities for preterm lung health research across the lifespan: a community priority setting partnership
Background: It is essential to embed patient and public perspectives into every stage of the research journey, including setting the future research agenda. The substantial gaps in our understanding of prematurity-associated lung disease presented a timely opportunity to determine the community’s research priorities. Objective: To conduct a priority setting partnership (PSP) to determine the top 10 research priorities for preterm lung health. Design: We undertook a modified James Lind Alliance methodology comprising three main stages: (1) an idea generating survey with open questions to ascertain the community’s most important ideas for future preterm lung health research, (2) prioritisation survey to distill the main themes into a shortlist of 20 and (3) consensus workshop where participants were tasked with ranking their final top 10. This PSP is reflective of the view of preterm-born individuals, parents of preterm children and healthcare professionals in an Australian healthcare setting. Results: We collated 144 submissions from the idea generating survey from which 27 prioritisation themes were developed. From the 150 prioritisation survey responses, the 20 themes receiving the most votes were taken to the consensus workshop . Participants identified the following top 10: (1) lifelong impacts; (2) interventions, treatments or supports; (3) ongoing lung health follow-up; (4) diagnostic tools, resources and education for primary healthcare providers; (5) resources to inform and empower families; (6) relationship to physical health and developmental issues; (7) preventing and/or treating lung infections; (8) additional supports, resources and research for minority groups; (9) impact on mental well-being; and (10) likelihood of asthma diagnosis. Conclusion: Priorities identified through the PSP will be invaluable in informing future research into prematurity-associated lung disease.
- Open Access
- 7 March 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (3)
Prematurity-associated lung disease: is it asthma?
Shareable abstract Not all wheeze is “asthma” in those born very preterm. Further work is needed to better understand the aetiology of prematurity-associated lung disease and the best treatments for this population.https://bit.ly/3Tko3vi
- 7 March 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (3)
Open AccessPrematurity-associated lung disease: is it asthma?
Shareable abstract Not all wheeze is “asthma” in those born very preterm. Further work is needed to better understand the aetiology of prematurity-associated lung disease and the best treatments for this population.https://bit.ly/3Tko3vi
- Top Cited Papers
- 14 November 2023
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 12 (2) , 167-180
Unravelling the respiratory health path across the lifespan for survivors of preterm birth
- 14 November 2023
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 12 (2) , 167-180
Top Cited PapersUnravelling the respiratory health path across the lifespan for survivors of preterm birth
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA4453
Investigating the relationship between inflammatory biomarkers and lung function in survivors of very preterm birth
Introduction: Chronic respiratory symptoms in survivors of preterm birth may be underpinned by active pulmonary inflammation, however limited evidence exists to support this theory. Our study aimed to assess if inflammatory biomarkers were correlated to lung function in those born very preterm (0.05). Conclusion: Spirometry data was not correlated to systemic inflammation; however pulmonary inflammation was unable to be directly assessed. Systemic findings of elevated 8-isoprostane highlight the ongoing role of oxidative stress in those born preterm.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA4453
Investigating the relationship between inflammatory biomarkers and lung function in survivors of very preterm birth
Introduction: Chronic respiratory symptoms in survivors of preterm birth may be underpinned by active pulmonary inflammation, however limited evidence exists to support this theory. Our study aimed to assess if inflammatory biomarkers were correlated to lung function in those born very preterm (0.05). Conclusion: Spirometry data was not correlated to systemic inflammation; however pulmonary inflammation was unable to be directly assessed. Systemic findings of elevated 8-isoprostane highlight the ongoing role of oxidative stress in those born preterm.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , OA1439
Prematurity-associated lung disease is frequently mis-diagnosed as asthma
Introduction: Ongoing respiratory symptoms throughout childhood is often diagnosed as asthma in preterm children. Whether prematurity-associated lung disease (PALD) is actually asthma is subject to intense debate. The recent ERS clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years (Gaillard et al. ERJ 2022) advocates for the use of two positive, evidence-based tests to confirm the diagnosis of asthma. We used the 2022 ERS guidelines to determine the rates of asthma in children born very-preterm (≤32 weeks gestation). Methods: Preterm children (N=128; mean±SD age=10.4±2.2) completed an ISAAC respiratory questionnaire, underwent spirometry, bronchodilator response (BDR) and fractional exhaled nitric oxide (FeNO) testing. A diagnosis of asthma was defined by two positive tests of either: a positive BDR (≥12% Δ in FEV1) and/or abnormal spirometry (FEV1 z-score<-1.645) and/or high FeNO (≥25ppb). Results: Respiratory symptoms were reported by 45% of the cohort in the past 3 months, with 25% of the cohort having previously received a clinical diagnosis of asthma. 51 individuals (39.8%) had at least one positive diagnostic for asthma (BDR, abnormal spirometry or high FeNO), however only 14% of the cohort met the new diagnostic criteria for asthma. Of those in the cohort with a previous clinical diagnosis of asthma (n=32), 12.5% (n=4) met the new asthma diagnostic criteria. Of the 18 individuals who met the new diagnostic criteria, only 3 reported any respiratory symptoms. Conclusion: Prematurity-associated lung disease is frequently mis-diagnosed as asthma in those born very-preterm. However, there is likely a subset that do fit the asthma phenotype and may benefit from asthma treatment.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , OA1439
Prematurity-associated lung disease is frequently mis-diagnosed as asthma
Introduction: Ongoing respiratory symptoms throughout childhood is often diagnosed as asthma in preterm children. Whether prematurity-associated lung disease (PALD) is actually asthma is subject to intense debate. The recent ERS clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years (Gaillard et al. ERJ 2022) advocates for the use of two positive, evidence-based tests to confirm the diagnosis of asthma. We used the 2022 ERS guidelines to determine the rates of asthma in children born very-preterm (≤32 weeks gestation). Methods: Preterm children (N=128; mean±SD age=10.4±2.2) completed an ISAAC respiratory questionnaire, underwent spirometry, bronchodilator response (BDR) and fractional exhaled nitric oxide (FeNO) testing. A diagnosis of asthma was defined by two positive tests of either: a positive BDR (≥12% Δ in FEV1) and/or abnormal spirometry (FEV1 z-score<-1.645) and/or high FeNO (≥25ppb). Results: Respiratory symptoms were reported by 45% of the cohort in the past 3 months, with 25% of the cohort having previously received a clinical diagnosis of asthma. 51 individuals (39.8%) had at least one positive diagnostic for asthma (BDR, abnormal spirometry or high FeNO), however only 14% of the cohort met the new diagnostic criteria for asthma. Of those in the cohort with a previous clinical diagnosis of asthma (n=32), 12.5% (n=4) met the new asthma diagnostic criteria. Of the 18 individuals who met the new diagnostic criteria, only 3 reported any respiratory symptoms. Conclusion: Prematurity-associated lung disease is frequently mis-diagnosed as asthma in those born very-preterm. However, there is likely a subset that do fit the asthma phenotype and may benefit from asthma treatment.
- Open Access
- 4 August 2023
- Published by Wiley in Pediatric Pulmonology
- Vol. 58 (11) , 3122-3132
Oscillometry and spirometry are not interchangeable when assessing the bronchodilator response in children and young adults born preterm
Introduction: The European Respiratory Society Oscillometry Taskforce identified that clinical correlates of bronchodilator responses are needed to advance oscillometry in clinical practice. The understanding of bronchodilator‐induced oscillometry changes in preterm lung disease is poor. Here we describe a comparison of bronchodilator assessments performed using oscillometry and spirometry in a population born very preterm and explore the relationship between bronchodilator‐induced changes in respiratory function and clinical outcomes.Methods: Participants aged 6–23 born ≤32 (N = 288; 132 with bronchopulmonary dysplasia) and ≥37 weeks' gestation (N = 76, term‐born controls) performed spirometry and oscillometry. A significant bronchodilator response (BDR) to 400 μg salbutamol was classified according to published criteria.Results: A BDR was identified in 30.9% (n = 85) of preterm‐born individuals via spirometry and/or oscillometry, with poor agreement between spirometry and oscillometry definitions (k = 0.26; 95% confidence interval [CI] 0.18–0.40, p < .001). Those born preterm with a BDR by oscillometry but not spirometry had increased wheeze (33% vs. 11%, p = .010) and baseline resistance (Rrs5 z‐score mean difference (MD) = 0.86, 95% CI 0.07–1.65, p = .025), but similar baseline spirometry to the group without a BDR (forced expiratory volume in 1 s [FEV1] z‐score MD = −0.01, 95% CI −0.66 to 0.68, p > .999). Oscillometry was more feasible than spirometry (95% success rate vs. 85% (FEV1), 69% (forced vital capacity) success rate, p < .001), however being born preterm did not affect test feasibility.Conclusion: In the preterm population, oscillometry is a feasible and clinically useful supportive test to assess the airway response to inhaled salbutamol. Changes measured by oscillometry reflect related but distinct physiological changes to those measured by spirometry, and thus these tests should not be used interchangeably.
- 4 August 2023
- Published by Wiley in Pediatric Pulmonology
- Vol. 58 (11) , 3122-3132
Open AccessOscillometry and spirometry are not interchangeable when assessing the bronchodilator response in children and young adults born preterm
Introduction: The European Respiratory Society Oscillometry Taskforce identified that clinical correlates of bronchodilator responses are needed to advance oscillometry in clinical practice. The understanding of bronchodilator‐induced oscillometry changes in preterm lung disease is poor. Here we describe a comparison of bronchodilator assessments performed using oscillometry and spirometry in a population born very preterm and explore the relationship between bronchodilator‐induced changes in respiratory function and clinical outcomes.Methods: Participants aged 6–23 born ≤32 (N = 288; 132 with bronchopulmonary dysplasia) and ≥37 weeks' gestation (N = 76, term‐born controls) performed spirometry and oscillometry. A significant bronchodilator response (BDR) to 400 μg salbutamol was classified according to published criteria.Results: A BDR was identified in 30.9% (n = 85) of preterm‐born individuals via spirometry and/or oscillometry, with poor agreement between spirometry and oscillometry definitions (k = 0.26; 95% confidence interval [CI] 0.18–0.40, p < .001). Those born preterm with a BDR by oscillometry but not spirometry had increased wheeze (33% vs. 11%, p = .010) and baseline resistance (Rrs5 z‐score mean difference (MD) = 0.86, 95% CI 0.07–1.65, p = .025), but similar baseline spirometry to the group without a BDR (forced expiratory volume in 1 s [FEV1] z‐score MD = −0.01, 95% CI −0.66 to 0.68, p > .999). Oscillometry was more feasible than spirometry (95% success rate vs. 85% (FEV1), 69% (forced vital capacity) success rate, p < .001), however being born preterm did not affect test feasibility.Conclusion: In the preterm population, oscillometry is a feasible and clinically useful supportive test to assess the airway response to inhaled salbutamol. Changes measured by oscillometry reflect related but distinct physiological changes to those measured by spirometry, and thus these tests should not be used interchangeably.
- Open Access
- 25 July 2023
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 66 (3) , 344-352
The cost of respiratory hospitalizations in children with cerebral palsy
Aim: To establish the burden of respiratory illness in cerebral palsy (CP) on the Western Australian health care system by quantifying the costs of respiratory hospitalizations in children with CP, compared with non‐respiratory hospitalizations.Method: A 2‐year (2014–2015) retrospective study using linked hospital data (excluding emergency department visits), in a population of children with CP in Western Australia aged 18 years and under (median age at hospitalization 7 years; interquartile range 5–12 years).Results: In 671 individuals (57% male) there were 726 emergency hospitalizations, and 1631 elective hospitalizations. Although there were more elective hospitalizations, emergency hospitalizations were associated with longer stays in hospital, and more days in an intensive care unit, resulting in a higher total cost of emergency hospitalizations than elective hospitalizations (total costs: emergency AU$7 748 718 vs elective AU$6 738 187). ‘Respiratory’ was the leading cause of emergency hospitalizations, contributing to 36% of all emergency admission costs. For a group of high‐cost inpatient users (top 5% of individuals with the highest total inpatient costs) the most common reason for hospitalization was ‘respiratory’. Where non‐respiratory admissions were complicated by an additional respiratory diagnosis, length of stay was greater.Interpretation: Respiratory hospitalizations in CP are a significant driver of health care costs. In the paediatric group, they are a burden for a subgroup of children with CP.What this paper adds: Respiratory illness is the most costly area for unplanned, emergency hospitalizations for children and young people with cerebral palsy. The top 5% of individuals with the highest total inpatient costs account for a disproportionate amount of health care costs.
- 25 July 2023
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 66 (3) , 344-352
Open AccessThe cost of respiratory hospitalizations in children with cerebral palsy
Aim: To establish the burden of respiratory illness in cerebral palsy (CP) on the Western Australian health care system by quantifying the costs of respiratory hospitalizations in children with CP, compared with non‐respiratory hospitalizations.Method: A 2‐year (2014–2015) retrospective study using linked hospital data (excluding emergency department visits), in a population of children with CP in Western Australia aged 18 years and under (median age at hospitalization 7 years; interquartile range 5–12 years).Results: In 671 individuals (57% male) there were 726 emergency hospitalizations, and 1631 elective hospitalizations. Although there were more elective hospitalizations, emergency hospitalizations were associated with longer stays in hospital, and more days in an intensive care unit, resulting in a higher total cost of emergency hospitalizations than elective hospitalizations (total costs: emergency AU$7 748 718 vs elective AU$6 738 187). ‘Respiratory’ was the leading cause of emergency hospitalizations, contributing to 36% of all emergency admission costs. For a group of high‐cost inpatient users (top 5% of individuals with the highest total inpatient costs) the most common reason for hospitalization was ‘respiratory’. Where non‐respiratory admissions were complicated by an additional respiratory diagnosis, length of stay was greater.Interpretation: Respiratory hospitalizations in CP are a significant driver of health care costs. In the paediatric group, they are a burden for a subgroup of children with CP.What this paper adds: Respiratory illness is the most costly area for unplanned, emergency hospitalizations for children and young people with cerebral palsy. The top 5% of individuals with the highest total inpatient costs account for a disproportionate amount of health care costs.
- Open Access
Risk factors for poorer respiratory outcomes in adolescents and young adults born preterm
Rationale The respiratory outcomes for adult survivors of preterm birth in the postsurfactant era are wide-ranging with prognostic factors, especially those encountered after the neonatal period, poorly understood. Objectives To obtain comprehensive ‘peak’ lung health data from survivors of very preterm birth and identify neonatal and life-course risk factors for poorer respiratory outcomes in adulthood. Methods 127 participants born ≤32 weeks gestation (64%, n=81 with bronchopulmonary dysplasia (BPD), initially recruited according to a 2 with-BPD:1 without-BPD strategy), and 41 term-born controls completed a lung health assessment at 16–23 years, including lung function, imaging and symptom review. Risk factors assessed against poor lung health included neonatal treatments, respiratory hospitalisation in childhood, atopy and tobacco smoke exposure. Measurements and main results Young adults born prematurely had greater airflow obstruction, gas trapping and ventilation inhomogeneity, in addition to abnormalities in gas transfer and respiratory mechanics, compared with term. Beyond lung function, we observed greater structural abnormalities, respiratory symptoms and inhaled medication use. A previous respiratory admission was associated with airway obstruction; mean forced expiratory volume in 1 s/forced vital capacity z-score was −0.561 lower after neonatal confounders were accounted for (95% CI −0.998 to –0.125; p=0.012). Similarly, respiratory symptom burden was increased in the preterm group with a respiratory admission, as was peribronchial thickening (6% vs 23%, p=0.010) and bronchodilator responsiveness (17% vs 35%, p=0.025). Atopy, maternal asthma and tobacco smoke exposure did not influence lung function or structure at 16–23 years in our preterm cohort. Conclusions Even after accounting for the neonatal course, a respiratory admission during childhood remained significantly associated with reduced peak lung function in the preterm-born cohort, with the largest difference seen in those with BPD. A respiratory admission during childhood should, therefore, be considered a risk factor for long-term respiratory morbidity in those born preterm, especially for individuals with BPD.
Open AccessRisk factors for poorer respiratory outcomes in adolescents and young adults born preterm
Rationale The respiratory outcomes for adult survivors of preterm birth in the postsurfactant era are wide-ranging with prognostic factors, especially those encountered after the neonatal period, poorly understood. Objectives To obtain comprehensive ‘peak’ lung health data from survivors of very preterm birth and identify neonatal and life-course risk factors for poorer respiratory outcomes in adulthood. Methods 127 participants born ≤32 weeks gestation (64%, n=81 with bronchopulmonary dysplasia (BPD), initially recruited according to a 2 with-BPD:1 without-BPD strategy), and 41 term-born controls completed a lung health assessment at 16–23 years, including lung function, imaging and symptom review. Risk factors assessed against poor lung health included neonatal treatments, respiratory hospitalisation in childhood, atopy and tobacco smoke exposure. Measurements and main results Young adults born prematurely had greater airflow obstruction, gas trapping and ventilation inhomogeneity, in addition to abnormalities in gas transfer and respiratory mechanics, compared with term. Beyond lung function, we observed greater structural abnormalities, respiratory symptoms and inhaled medication use. A previous respiratory admission was associated with airway obstruction; mean forced expiratory volume in 1 s/forced vital capacity z-score was −0.561 lower after neonatal confounders were accounted for (95% CI −0.998 to –0.125; p=0.012). Similarly, respiratory symptom burden was increased in the preterm group with a respiratory admission, as was peribronchial thickening (6% vs 23%, p=0.010) and bronchodilator responsiveness (17% vs 35%, p=0.025). Atopy, maternal asthma and tobacco smoke exposure did not influence lung function or structure at 16–23 years in our preterm cohort. Conclusions Even after accounting for the neonatal course, a respiratory admission during childhood remained significantly associated with reduced peak lung function in the preterm-born cohort, with the largest difference seen in those with BPD. A respiratory admission during childhood should, therefore, be considered a risk factor for long-term respiratory morbidity in those born preterm, especially for individuals with BPD.
- Open Access
- 6 April 2023
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 9 (3)
Increasing airway obstruction through life following bronchopulmonary dysplasia: a meta-analysis
Background: Few studies exist investigating lung function trajectories of those born preterm; however growing evidence suggests some individuals experience increasing airway obstruction throughout life. Here we use the studies identified in a recent systematic review to provide the first meta-analysis investigating the impact of preterm birth on airway obstruction measured by the forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) ratio.Methods: Cohorts were included for analysis if they reported FEV1/FVC in survivors of preterm birth (1/FVC were seen in all individuals born preterm (SMD −0.56), with greater differences seen in those with BPD (SMD −0.87) than those without BPD (SMD −0.45). Meta-regression identified age as a significant predictor of FEV1/FVC in those with BPD with the FEV1/FVC ratio moving −0.04sds away from the term control population for every year of increased age.Conclusions: Survivors of preterm birth have significantly increased airway obstruction compared to those born at term with larger differences in those with BPD. Increased age is associated with a decline in FEV1/FVC values suggesting increased airway obstruction over the life course.
- 6 April 2023
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 9 (3)
Open AccessIncreasing airway obstruction through life following bronchopulmonary dysplasia: a meta-analysis
Background: Few studies exist investigating lung function trajectories of those born preterm; however growing evidence suggests some individuals experience increasing airway obstruction throughout life. Here we use the studies identified in a recent systematic review to provide the first meta-analysis investigating the impact of preterm birth on airway obstruction measured by the forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) ratio.Methods: Cohorts were included for analysis if they reported FEV1/FVC in survivors of preterm birth (1/FVC were seen in all individuals born preterm (SMD −0.56), with greater differences seen in those with BPD (SMD −0.87) than those without BPD (SMD −0.45). Meta-regression identified age as a significant predictor of FEV1/FVC in those with BPD with the FEV1/FVC ratio moving −0.04sds away from the term control population for every year of increased age.Conclusions: Survivors of preterm birth have significantly increased airway obstruction compared to those born at term with larger differences in those with BPD. Increased age is associated with a decline in FEV1/FVC values suggesting increased airway obstruction over the life course.